Everence Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,050
Closed -$317K 991
2024
Q3
$317K Buy
+7,050
New +$317K 0.02% 566